Clinical • Journal • Checkpoint inhibition • Tumor mutational burden • Tumor-infiltrating lymphocyte • PD(L)-1 Biomarker • IO biomarker • Metastases
|
TMB (Tumor Mutational Burden) • STK11 (Serine/threonine kinase 11)
|
STK11 mutation • PD-L1 negative • TMB-L • PD-L1 negative + TMB-L
|
Amtagvi (lifileucel) • LN-145